Learn, Analyse & Invest
only with
only with
+91
Download Orca
Biogen Pharmachem Industries Ltd.
Biogen Pharmachem
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹42.42 Cr.
| EX-Date | Purpose |
|---|---|
| 18 05 2021 | Audited Results |
| 13 08 2021 | Quarterly Results |
| 13 11 2021 | Quarterly Results |
| 12 02 2022 | Quarterly Results |
| 25 05 2022 | Audited Results |
| 03 08 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 02 02 2023 | Quarterly Results |
| 08 05 2023 | Audited Results |
| 10 08 2023 | Quarterly Results |
| 01 11 2023 | Quarterly Results |
| 09 01 2024 | Inter alia, to consider the appointment and Resignation of Director. |
| 22 01 2024 | Quarterly Results |
| 13 11 2024 | Quarterly Results |
| 05 02 2025 | Quarterly Results & Inter alia, to consider and approve:- 1.) To approve and take on record the Un-Audited Financia l Results of the Company for the quarter ended on 31st December 2024. 2.) To approve and consider the appointment of Mr. Kelash Bunkar as Whole time Director and Chief Financial Officer of the Company. 3.) To consider the resignation of Mr. Niraj Vaghela from designation of Whole time Director and Chief Financial Officer of the Company. 4.)To approve and consider the appointment of Mr. Aman Patel as Director of the Company. 5.) To consider the resignation of Ms. Komal Chauhan from directorship of the Company. 6.) Any other matter with the permission of the board which the Board may think fit. |
| 23 05 2025 | Audited Results |
| 23 07 2025 | Quarterly Results |
| 07 11 2025 | Quarterly Results |
| 03 02 2026 | Quarterly Results(Cancelled) (Cancelled) |
| 11 02 2026 | Quarterly Results |
| 23 03 2026 | Bonus issue |
News
No News data available
